Dapagliflozin vs Trastuzumab

Dapagliflozin vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Dapagliflozin and Trastuzumab.

Mechanism of Action

Dapagliflozin: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Dapagliflozin — 12.9 hours; Trastuzumab — 28 days.

Chemical Properties

Molecular Formula: Dapagliflozin — C21H25ClO6.

Molecular Weight: Dapagliflozin — 408.8730 g/mol.

Type: Dapagliflozin — Small molecule; Trastuzumab — Antibody.